Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

<p>Abstract</p> <p>The matrix protein osteopontin has been shown to be a marker of osteoclastic activity in multiple myeloma patients, as well as a regulator of angiogenesis. We measured serum levels of osteopontin in 50 untreated multiple myeloma patients (in 25, also after treatm...

Full description

Bibliographic Details
Main Authors:	Kotsis Vasileios, Alegakis Athanasios, Tsirakis George, Pappa Constantina, Miyakis Spiros, Sfiridaki Aikaterini, Stathopoulos Efstathios, Alexandrakis Michael
Format:	Article
Language:	English
Published:	BMC 2011-05-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/4/1/22

Similar Items

Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients
by: G. Tsirakis, et al.
Published: (2011-08-01)

Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease
by: Vladimir Gerov, et al.
Published: (2023-11-01)

Angiogenin and osteopontin and coronary collateral circulation
by: Joob Beuy, et al.
Published: (2019-09-01)

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
by: Aristea-Maria Papanota, et al.
Published: (2021-07-01)

Osteopontin Promotes Bone Destruction in Periapical Periodontitis by Activating the NF-κB Pathway
by: Ming Dong, et al.
Published: (2018-09-01)

Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight
by: Anne-Sophie Lamort, et al.
Published: (2019-08-01)

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
by: Salim S. Hayek, et al.
Published: (2021-08-01)

Host-derived MMP-7 decreases myeloma progression in vivo: An unexpected role for MMP-7 and osteopontin in myeloma pathogenesis
by: Lwin, S, et al.
Published: (2011)

Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors
by: Ali Nazarizadeh, et al.
Published: (2021-08-01)

S8 Osteopontin as an airway epithelial tumour promoter
by: Psallidas, I, et al.
Published: (2016)

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
by: Aditi Gupta, et al.
Published: (2013-05-01)

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
by: Maria-Alexandra Papadimitriou, et al.
Published: (2023-04-01)

Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
by: Danny T M Leung, et al.
Published: (2016-01-01)

LSC Abstract – Osteopontin as an airway epithelial tumor promoter
by: Psallidas, I, et al.
Published: (2016)

The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
by: Hadas Lavi, et al.
Published: (2017-01-01)

Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
by: Kitboklang Khongsti, et al.
Published: (2021-11-01)

Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma
by: Despina Fotiou, et al.
Published: (2022-12-01)

Osteopontin in Cardiovascular Diseases
by: Kohsuke Shirakawa, et al.
Published: (2021-07-01)

Osteopontin in Pulmonary Hypertension
by: Argen Mamazhakypov, et al.
Published: (2023-05-01)

Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
by: Kanellakis, N, et al.
Published: (2016)

Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma
by: Rafael Saup, et al.
Published: (2023-03-01)

The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions
by: Louvrou Niki, et al.
Published: (2008-04-01)

Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression
by: Xing-Xing Yao, et al.
Published: (2017-04-01)

Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis
by: Giopanou, I, et al.
Published: (2016)

Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
by: Priscilla Cury de Camargo Cury, et al.
Published: (2020-04-01)

Evaluation of Angiogenesis in Multiple Myeloma by VEGF Immunoexpression and Microvessel Density
by: Anshu Palta, et al.
Published: (2020-03-01)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
by: Vasileios Lazaris, et al.
Published: (2021-03-01)

Immunoregulatory Roles of Osteopontin in Diseases
by: Lebei Wang, et al.
Published: (2024-01-01)

Milk Osteopontin and Human Health
by: Esben S. Sørensen, et al.
Published: (2023-05-01)

Osteopontin and its clinical significance
by: Meenakshisundaram Ramachandran, et al.
Published: (2009-07-01)

High levels of circulating osteopontin in inflammatory lung disease regardless of SARS‐CoV‐2 infection
by: Giuseppe Cappellano, et al.
Published: (2021-11-01)

High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
by: Giuseppe Cappellano, et al.
Published: (2021-05-01)

The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion
by: Kadri Murat Gürses, et al.
Published: (2019-08-01)

Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature
by: Krambovitis Elias, et al.
Published: (2008-03-01)

Lactoferrin, Osteopontin and Lactoferrin–Osteopontin Complex: A Critical Look on Their Role in Perinatal Period and Cardiometabolic Disorders
by: Emile Levy, et al.
Published: (2023-03-01)

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2023-07-01)

Circulating markers of angiogenesis and endotheliopathy in COVID-19
by: Alexander B. Pine, et al.
Published: (2020-11-01)

Angiogenesis in the Outer Membrane of Chronic Subdural Hematomas through Thrombin-Cleaved Osteopontin and the Integrin α9 and Integrin β1 Signaling Pathways
by: Koji Osuka, et al.
Published: (2023-05-01)

The Multifaceted Role of Osteopontin in Prostate Pathologies
by: Samara V. Silver, et al.
Published: (2023-10-01)

Osteopontin Is Associated with Multiple Sclerosis Relapses
by: Mario Stampanoni Bassi, et al.
Published: (2023-01-01)